Researchers found that fewer dupilumab-receiving patients had high mucus plug scores at week 24 than at baseline (32.8 vs 67.2%). HealthDay News — Dupilumab reduces mucus plug scores and improves lung ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is ...

WASHINGTON -- Mucus plugs obstructing the airways of patients with chronic obstructive pulmonary disease (COPD) were associated with higher all-cause mortality compared with no mucus plugs, according ...

WASHINGTON -- Dupilumab (Dupixent) reduced airway inflammation and increased lung capacity in patients with uncontrolled, moderate-to-severe asthma, while also reducing troublesome mucus plugs, a ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Dupilumab for uncontrolled asthma improved mucus ...

Please provide your email address to receive an email when new articles are posted on . 58% of patients had at least one mucus plug. Patients with four or more mucus plugs had a median FEV 1 of about ...

After only 28 days of treatment with ARCT-032 (10 mg), 4 out of 6 Class I CF participants exhibited encouraging reduction of mucus plug number and mucus volume 12-week study enrolling up to 20 CF ...

MONDAY, Nov. 3, 2025 (HealthDay News) -- Dupilumab reduces mucus plug scores and improves lung function in patients with moderate-to-severe asthma and high baseline mucus plug scores, according to a ...